Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Breast Cancer treatment details. Chemotherapy. Oslo University Hospital, Oslo, Norway



Survival: 15.3 months
   
Toxicity Grade: 4
   
Treatments: Chemotherapy
   
Drugs:
Country: Norway
   
City/State/Province: Oslo
   
Hospital: Oslo University Hospital
   
Journal: Link
   
Date: 1/2012

Description:
Patients:
This phase II study involved women with advanced or metastatic breast cancer. The patients were divided into two separate treatment groups. Group A consisted of 19 patients with a median age of 52 years. Group B had 18 patients with a median age of 53 years.

Treatment:
Patients in group A were treated with the chemotherapy agents capecitabine and docetaxel.
Group B patients were treated with the chemotherapy agents paclitaxel and capecitabine.

Toxicities:
The most severe adverse events in group A were of grade 4 and included grade3/4 neutropenia (12 cases) and leukopenia (9).
The most severe adverse events in group B were of grade 4 and included grade3/4 hand-foot skin reaction (4 cases) and neutropenia (3).

Results:
The median overall survival rates for groups A and B were 15.3 and 30.7 months, respectively.

Correspondence: Dr. E.A. Wist; email: erik.wist@medisin.uio.no

E-mail to a Friend Email Physician More Information